Program for clinical outsourcing and development professionals

Download PDF Copy

Nov 4 2009

The Institute for International Research is pleased to announce that as a chief component of its global branding strategy, the industry-leading Partnerships with CROs event is now known as Partnerships in Clinical Trials.

In the nineteen years since the inception of the event, both the biopharmaceutical industry and Partnerships have experienced tremendous growth as outsourcing to suppliers has become more than simply a tactic to control costs, but a leading strategic directive to ensure speed, quality and value of new medicines.

“The name Partnerships in Clinical Trials reflects the comprehensive nature of the program, which is the must-attend annual event for clinical outsourcing and development professionals and is increasingly valuable to those with responsibilities in clinical operations, clinical project management, drug safety and quality,” said program director Lesly Atlas. “Our new name also represents our widening global reach with Partnerships in Clinical Trials events already taking place in Europe and the premier of our APAC event in Singapore this December. Collectively the Partnerships in Clinical Trials brand serves over 35 countries.”

Notable speakers include:

Tom Daschle, Former Senate Majority and Minority Leader, US Senate
David Holveck, President and CEO, Endo Pharmaceuticals
Nancy Simonian, MD, Chief Medical Officer and Senior Vice President of Clinical, Medical, and Regulatory Affairs, Millennium: The Takeda Oncology Company
Ethan Zohn, Winner of Survivor: Africa Chris Anderson, Editor-in-Chief, Wired Magazine and NYT Bestselling Author, The Long Tail: Why the Future of Business is Selling Less of More
Thomas Senderovitz, MD, Vice President, Global Exploratory Development, UCB Pharma - Belgium
Jason Hwang, MD, Executive Director, Innosight Institute
Deirdre BeVard, Vice President, Clinical Operations and Data Management, Endo Pharmaceuticals
Reinilde Heyrman, Vice President, Clinical Development and Operations, Daiichi Sankyo Pharma Development
Peter Carberry, Senior Vice President, Global Development Operations, Astellas Pharmaceuticals
Kenneth Getz, Senior Research Fellow, Tufts Center for the Study of Drug Development
John Balian, MD, Senior Vice President, Global Pharmacovigilance and Epidemiology, BRISTOL-MYERS SQUIBB
Amrit Ray, MD, MBA, FCMI, Chief Safety Officer, Head, Global Medical Safety, JOHNSON & JOHNSON PHARMACEUTICALS GROUP
Philippe Van der Auwera, MD, PhD, Global Head of Safety Risk Management (PDS) & EU-QPPV, Pharma Development, F.HOFFMANN-LA ROCHE LTD - Switzerland
Mariette Boerstoel-Streefland, MD, MBA, MS(epi), Chief Safety Officer, Vice President, Global Drug Safety, FOREST RESEARCH INSTITUTE
Juergen Schmider MD, PhD, Corporate Safety Officer and Vice President Global Pharmacovigilance & Epidemiology, CEPHALON, INC
And many more – complete program information will soon be available at www.clinicaltrialpartnerships.com.